Pregnancy in a patient receiving busulphan for chronic myeloid leukaemia

A 33-year-old Malay lady with chronic myeloid leukaemia (CML) became amenorrhoeic during therapy with busulphan. Pregnancy was diagnosed via a urine pregnancy test and an ultrasound confirmed a viable foetus at 16 weeks. The busulphan was stopped. Her pregnancy was unremarkable and continued till te...

Full description

Saved in:
Bibliographic Details
Published inSingapore medical journal Vol. 35; no. 1; pp. 102 - 103
Main Authors NORHAYA, M. R, CHEONG, S. K, HAMIDAH, N. H, AINOON, O
Format Journal Article
LanguageEnglish
Published Singapore Singapore Medical Association 01.02.1994
Subjects
Adult
Biological and medical sciences
Busulfan - administration & dosage
Busulfan - adverse effects
Female
Gynecology. Andrology. Obstetrics
Humans
Infant, Newborn
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukocyte Count - drug effects
Male
Management. Prenatal diagnosis
Medical sciences
Pregnancy
Pregnancy Complications, Neoplastic - drug therapy
Pregnancy. Fetus. Placenta
Case study
Pregnancy
Human
Myeloproliferative syndrome
Chemotherapy
Treatment
Chronic myelocytic leukemia
Female
Malignant hemopathy
Online AccessGet full text

Cover

More Information
Summary:A 33-year-old Malay lady with chronic myeloid leukaemia (CML) became amenorrhoeic during therapy with busulphan. Pregnancy was diagnosed via a urine pregnancy test and an ultrasound confirmed a viable foetus at 16 weeks. The busulphan was stopped. Her pregnancy was unremarkable and continued till term. She delivered a healthy child.
ISSN:0037-5675